NPY Y1 receptors are involved in cardio-respiratory responses to intravenous injection of neuropeptide Y in anaesthetized rats

Pharmacological Research

Volumn 62, Issue 5, 2010, Pages 444-449

  Kaczyńska, Katarzyna ^a   Szereda Przestaszewska, Małgorzata ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Lung afferents; Neuropeptide Y; NPY Y1, NPY Y2 receptors; Pattern of breathing; Supranodose vagotomy

Indexed keywords

BMS 193885; N [2 [1,2 DIHYDRO 3,5(4H) DIOXO 1,2 DIPHENYL 1,2,4 TRIAZOL 4 YL]ETHYL] N2 [[1 [2 [4 [5,11 DIHYDRO 6(6H) OXODIBENZ[B,E]AZEPIN 11 YL] 1 PIPERAZINYL] 2 OXOETHYL]CYCLOPENTYL]ACETYL]ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y1 RECEPTOR ANTAGONIST; NEUROPEPTIDE Y2 RECEPTOR; UNCLASSIFIED DRUG;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; BOLUS INJECTION; BRADYCARDIA; BREATHING PATTERN; BREATHING RATE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; DENERVATION; EXCITATION; HEART RATE; HYPERTENSION; LUNG MINUTE VOLUME; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RESPIRATORY FUNCTION; TIDAL VOLUME; VAGOTOMY; VAGUS NERVE;

ANIMALS; BLOOD PRESSURE; DIHYDROPYRIDINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; HEMODYNAMICS; MALE; NEUROPEPTIDE Y; PHENYLUREA COMPOUNDS; RATS; RATS, WISTAR; RECEPTORS, NEUROPEPTIDE Y; RESPIRATION; RESPIRATORY RATE; TIDAL VOLUME; VAGOTOMY; VAGUS NERVE;

EID: 77956899983     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2010.06.006     Document Type: Article

References (29)

1. Gehlert D.R. Introduction to the reviews on neuropeptide Y. Neuropeptides 2004, 38:135-140.
2. Silva A.P., Cavadas C., Grouzmann E. Neuropeptide Y and its receptors as potential therapeutic drug targets. Clin. Chim. Acta 2002, 326:3-25.
3. Lin S., Boey D., Herzog H. NPY and Y receptors: lessons from transgenic and knockout models. Neuropeptides 2004, 38:189-200.
4. Corder R., Pralong F.P., Muller A.F., Gaillard R.C. Regional distribution of neuropeptide Y-like immunoreactivity in human hypothalamus measured by immunoradiometric assay: possible influence of chronic respiratory failure on tissue levels. Neuroendocrinology 1990, 51:23-30.
5. Harfstrand A., Fuxe K., Terenius L., Kalia M. Neuropeptide Y-immunoreactive perikarya and nerve terminals in the rat medulla oblongata: relationship to cytoarchitecture and catecholaminergic cell groups. J. Comp. Neurol. 1987, 260:20-35.
6. Halliday G.M., Li Y.W., Oliver J.R., Joh T.H., Cotton R.G., Howe P.R., et al. The distribution of neuropeptide Y-like immunoreactive neurons in the human medulla oblongata. Neuroscience 1988, 26:179-191.
7. McLean K.J., Jarrott B., Lawrence A.J. Neuropeptide Y gene expression and receptor autoradiography in hypertensive and normotensive rat brain. Mol. Brain Res. 1996, 35:249-259.
8. Harfstrand A. Intraventricular administration of neuropeptide Y (NPY) induces hypotension, bradycardia and bradypnoea in the awake unrestrained rat counteraction by NPY-induced feeding behaviour. Acta Physiol. Scand. 1986, 128:121-123.
9. Barraco R.A., Ergene E., Dunbar J.C., El-Ridi M.R. Cardiorespiratory response patterns elicited by microinjections of neuropeptide Y in the nucleus tractus solitarius. Brain Res. Bull. 1990, 24:465-485.
10. Dunbar J.C., Ergene E., Anderson G.F., Barraco R.A. Decreased cardiorespiratory effects of neuropeptide Y in the nucleus tractus solitarius in diabetes. Am. J. Physiol. 1992, 262:R865-R871.
11. Morton K.D.R., McCloskey M.J.D., Potter E.K. Cardiorespiratory responses to intracerebroventricular injection of neuropeptide Y in anaesthetized dogs. Regul. Pept. 1999, 81:81-88.
12. Lundberg J.M., Terenius L., Hokfelt T., Martling C.R., Tatemoto K., Mutt V. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic functions. Acta Physiol. Scand. 1982, 116:477-480.
13. Pedrazini T., Seydoux J., Kunstner P., Aubert J.F., Grouzmann E., Beermann F., et al. Cardiovascular response, feeding behaviour and locomotor activity in mice lacking the NPY Y1 receptor. Nat. Med. 1998, 4:722-726.
14. Czyzyk-Krzeska M.F., Bayliss D.A., Seroogy K.B., Millhorn D.E. Gene expression for peptides in neurons of the petrosal and nodose ganglia in rat. Exp. Brain Res. 1991, 83:1-418.
15. Kummer W., Bachmann S., Neuhuber W.L., Hanze J., Lang R.E. Tyrosine-hydroxylase-containing vagal afferent neurons in the rat nodose ganglion are independent from neuropeptide-Y-containing populations and project to esophagus and stomach. Cell Tissue Res. 1993, 271:135-144.
16. Coelho E.F., Ferrari M.F.R., Maximino J.R., Fior-Chadi D.R. Change in the expression of NPY receptor subtypes Y1 and Y2 in central and peripheral neurons related to the control of blood pressure in rats following experimental hypertension. Neuropeptides 2004, 38:77-82.
17. Potter E.K., McCloskey D.I. Excitation of carotid body chemoreceptors by neuropeptide-Y. Respir. Physiol. 1987, 67:357-365.
18. Grundemar L., Hakanson R. Multiple neuropeptide Y receptors are involved in cardiovascular regulation Peripheral and central mechanisms. Gen. Pharmacol. 1993, 24:785-796.
19. Kondo H., Kuramoto H., Fujita T. Neuropeptide tyrosine-like immunoreactivity nerve fibers in the carotid body chemoreceptor of rats. Brain Res. 1986, 372:353-356.
20. Leblanc G.G., Trimmer B.A., Landis S.C. Neuropeptide Y-like immunoreactivity in rat cranial parasympathetic neurons: coexistence with vasoactive intestinal peptide and choline acetyltransferase. Proc. Natl. Acad. Sci. 1987, 84:3511-3515.
21. Kuwayama Y., Emson P.C., Stone R.A. Pterygopalatine ganglion cells contain neuropeptide Y. Brain Res. 1988, 446:219-224.
22. Ghilardi J.R., Allen C.J., Vigna S.R., McVey D.C., Mantyh P.W. Cholecystokinin and neuropeptide Y receptors on single rabbit vagal afferent ganglion neurons: site of prejunctional modulation of visceral sensory neurons. Brain Res. 1994, 633:33-40.
23. McLean K.J., Jarrott B., Lawrence A.J. Prepro-neuropeptide Y mRNA and NPY binding sites in human inferior vagal ganglia. NeuroReport 1997, 8:2317-2320.
24. 1 receptor antagonist. Eur. J. Pharmacol. 2008, 590:224-232.
25. 2 receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats. Br. J. Pharmacol. 2006, 148:703-713.
26. Kastin A.J., Akerstrom V. Nonsaturable entry of neuropeptide Y into brain. Am. J. Physiol. 1999, 276:E479-E482.
27. Yang S.N., Narvaez J.A., Bjelke B., Agnati L.F., Fuxe K. Microinjections of subpicomolar amounts of NPY (13-36) into the nucleus tractus solitarius of the rat counteract the vasodepressor responses of NPY (1-36) and of a NPY Y1 receptor agonist. Brain Res. 1993, 621:126-132.
28. Matsuda H., Brumowsky P.R., Kopp J., Pedrazini T., Hokfelt T. Distribution of neuropeptide YY1 receptors in rodent peripheral tissues. J. Comp. Neurol. 2002, 449:390-404.
29. Balasubramaniam A. Clinical potentials of neuropeptide Y family of hormones. Am. J. Surg. 2002, 183:430-434.